β1-Adrenergic receptor stimulation modulates immune response in cancer: a role for β-blockers in antineoplastic treatment?

Eur Heart J. 2024 Mar 14;45(11):870-871. doi: 10.1093/eurheartj/ehae008.

Authors

Daniela Pedicino¹, Massimo Volpe^{2

3}

Affiliations

¹ Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, Rome 00168, Italy.
² Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa1035, Rome, Italy.
³ IRCCS San Raffaele Roma, Via di Valcannuta 250, Rome, Italy.

PMID: 38240494
DOI: 10.1093/eurheartj/ehae008

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Antineoplastic Agents* / therapeutic use
Humans
Immunity
Neoplasms* / drug therapy
Receptors, Adrenergic

Substances

Adrenergic beta-Antagonists
Antineoplastic Agents
Receptors, Adrenergic